The Effects of Perioperative Dexmedetomidine Administration on Immune Suppression and Outcomes in Patients With Uterine Cancer Undergoing Radical Resection

NCT02896413 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Uterine Cancer

Interventions

DRUG: Dexmedetomidine group
DRUG: Control group

Sponsor

Yonsei University